{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:42:23Z","timestamp":1791988943451,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T00:00:00Z","timestamp":1527638400000},"content-version":"vor","delay-in-days":394,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","onlinejacc.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jacc.2017.03.568","type":"journal-article","created":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T20:48:32Z","timestamp":1495486112000},"page":"2606-2618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Seattle Heart Failure and Proportional Risk\u00a0Models Predict Benefit From Implantable\u00a0Cardioverter-Defibrillators"],"prefix":"10.1016","volume":"69","author":[{"given":"Kenneth C.","family":"Bilchick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeptha P.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Dharmarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Stukenborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Shadman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inder","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars H.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Dahlstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrik","family":"Sartipy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Swedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"O\u2019Conner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne C.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.03.568_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jama.292.3.344","article-title":"Trends in heart failure incidence and survival in a community-based population","volume":"292","author":"Roger","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.03.568_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa020265","article-title":"Long-term trends in the incidence of and survival with heart failure","volume":"347","author":"Levy","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.03.568_bib3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/hj.1999.v137.95495","article-title":"Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995","volume":"137","author":"Haldeman","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2017.03.568_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.03.568_bib5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.03.568_bib6","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/europace\/euq329","article-title":"Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with\u00a0ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis","volume":"12","author":"Theuns","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2017.03.568_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCULATIONAHA.106.637405","article-title":"Implantable cardioverter-defibrillators for primary prevention of sudden death in heart failure: are there enough bangs for the bucks?","volume":"114","author":"Stevenson","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.03.568_bib8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/CIRCULATIONAHA.108.816884","article-title":"Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population","volume":"120","author":"Levy","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.03.568_bib9","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle Heart Failure Model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.03.568_bib10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.03.568_bib11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jacc.2007.08.058","article-title":"Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction","volume":"51","author":"Goldenberg","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.03.568_bib12","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.jacc.2003.11.038","article-title":"Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II)","volume":"43","author":"Greenberg","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.03.568_bib13","doi-asserted-by":"crossref","first-page":"A17819","DOI":"10.1161\/circ.124.suppl_21.A17819","article-title":"Predicting the proportional risk of sudden cardiac death in a multicenter cohort [abstract]","volume":"124","author":"Shadman","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.03.568_bib14","first-page":"208","article-title":"Benefits of ICD therapy: connecting treatment decisions to individualized SCD risk estimates within SCD-HEFT - Seattle Proportional Risk Model [abstract]","volume":"42","author":"Levy","year":"2015","journal-title":"J Interv Card Electrophys"},{"key":"10.1016\/j.jacc.2017.03.568_bib15","first-page":"291","article-title":"Does the implantable cardioverter-defibrillator benefit vary with the estimated proportional risk of sudden death in heart failure patients?","volume":"3","author":"Levy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2017.03.568_bib16","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.amjcard.2004.08.046","article-title":"Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure","volume":"94","author":"Sullivan","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.03.568_bib17","first-page":"689","article-title":"Italian Network on Congestive Heart Failure: ten-year experience (in Italian)","volume":"7","author":"Fabbri","year":"2006","journal-title":"G\u00a0Ital Cardiol"},{"key":"10.1016\/j.jacc.2017.03.568_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/eurjhf\/hfp175","article-title":"Heart failure registry: a valuable tool for improving the management of patients with heart failure","volume":"12","author":"Jonsson","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2017.03.568_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.03.568_bib20","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A\u00a0randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.03.568_bib21","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJM199610103351504","article-title":"Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group","volume":"335","author":"Packer","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.03.568_bib22","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jacc.2012.07.009","article-title":"2012 ACCF\/AHA\/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"60","author":"Tracy","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.03.568_bib23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/eurjhf\/hfn048","article-title":"Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials","volume":"11","author":"Levy","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2017.03.568_bib24","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1001\/jama.2014.5310","article-title":"Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%","volume":"311","author":"Al-Khatib","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.03.568_bib25","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1161\/CIRCULATIONAHA.111.069245","article-title":"Important differences in mode of death between men and women with heart failure who would qualify\u00a0for a primary prevention implantable cardioverter-defibrillator","volume":"126","author":"Rho","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.03.568_bib26","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/heartjnl-2015-307634","article-title":"Individual patient data network meta-analysis of mortality effects of implantable cardiac devices","volume":"101","author":"Woods","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2017.03.568_bib27","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717368250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717368250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T07:54:40Z","timestamp":1719215680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109717368250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":27,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0735109717368250"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.03.568","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seattle Heart Failure and Proportional Risk\u00a0Models Predict Benefit From Implantable\u00a0Cardioverter-Defibrillators","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.03.568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}